Do age, race, or other demographics influence postpartum IUD compliance? The results of this retrospective chart review were presented at ACOG's Annual Clinical Meeting.
Typically used for long-term contraception, the intrauterine device (IUD) is also an effective emergency contraceptive if implanted after unprotected sex. Two IUDs, which are T-shaped pieces of plastic, are available in the United States.
When used under routine conditions, vaginal ring and combined oral contraceptives have similar venous thrombolism risks, according to a prospective, controlled, non-interventional cohort study.
Providers underestimate the intensity of patients’ pain during IUD insertion, and often misidentify the moment at which maximum pain occurs, according to a randomized trial of 200 women. Midlevel providers are slightly better at estimating pain intensity.
A recent study shows that health care professionals continue to have misconceptions about the safety of IUDs for nulliparous women.
Poll shows ob/gyn opinions are split on the federal mandate that private insurance plans cover the cost of birth control.
Should employers be required to provide insurance that includes free contraceptive coverage?
Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.
Oral contraceptives have long been considered an option for relieving symptoms of dysmenorrhea, but a 2009 Cochrane review cast doubt on that claim. Now, a new study out of Sweden offers contradictory evidence.
William Parker, MD discusses the use of MRI in diagnosing and managing uterine fibroids. Dr. Parker's upcoming Clinical Opinion article, “The utility of MRI for the surgical treatment of women with uterine fibroid tumors”, will be published in the American Journal of Obstetrics and Gynecology in 2012.